Disclosures for "Preclinical Evidence Supporting Pilavapadin as a Novel Oral Therapy for Spasticity"
-
Dr. Gopinathan has received personal compensation for serving as an employee of Lexicon Pharmaceuticals. Dr. Gopinathan has stock in Lexicon Pharmaceuticals.
-
Dr. Yang has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Tyle has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Levi has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Main has received personal compensation for serving as an employee of Lexicon Pharmaceuticals . Dr. Main has stock in Lexicon Pharmaceuticals .